Article
CytomX puts lead ADC on the block after phase 2 breast cancer data underwhelm
Rating:
0.0
Views:
39
Likes:
1
Library:
1
CytomX Therapeutics is pulling the plug on its lead candidate afte | CytomX Therapeutics is pulling the plug on its lead candidate after getting a look at phase 2 data. One of the arms hit its primary endpoint but the data fell short of the bar CytomX set for further development, leading it to halt work and seek a partner for the prospect.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value